The FemPulse bioelectronic device has eight individual electrodes to address a variety of neurosensory medical conditions. OAB is one such condition, in which bladder nerves excessively signal, causing the false sense of fullness underlying OAB. Sympathetic nerves promote bladder filling and parasympathetic nerves facilitate emptying. To treat OAB, FemPulse targets the sympathetic nerves involved in relaxation of the bladder and constriction of the urethral sphincter. The treatment is designed to prevent the abnormal nerve signaling to muscles of the bladder that are normally relaxed as the bladder fills. FemPulse directly influences the nerves causing OAB, rather than attempting to influence the muscles like other therapies.
